News & Stories
Danaher in action—business milestones, technological innovations and impact that circles the globe.
Primary tabs
03/31/2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part...
03/25/2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of: €750,000,000 principal amount of 1.700% senior notes due 2024 at an offering price of 99.931% of...
03/19/2020
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that the U.S. Federal Trade Commission (the "FTC") has accepted the proposed consent order in connection with Danaher's definitive...
02/20/2020
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on April 24, 2020 to...
01/30/2020
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2019. All results in this release reflect only continuing operations unless otherwise...